In 1983, I was delighted to publish my first paper in The American Journal of Pathology and I remember equally well preparing an overview for the Journal in 1990, concurrent with receiving the Warner-Lambert/Parke-Davis (now Pfizer) Award of the American Society of Investigative Pathology. I felt honored both times, recognizing the strength and reputation of the Journal in our field. Subsequently, given Nelson Fausto's almost 10 years of stewardship as Editor-in-Chief, the Journal has only gained in stature, now having by far the highest impact in the field. Last July, the Journal began a transition, completed January 1, 2001 , to a recast group of Editors. Our task of guiding the Journal over the next few years also happens in a remarkable year-what had been thought for years to be the 100th anniversary of this publication. Accordingly, I will say a few words concerning a centennial anniversary surprise and, subsequently, a few more words about our new group of editors. : "Voted that, to further the best interests of the (Harvard Medical) School, the Faculty requests each head of department to have at least a summary of the scientific investigations made in his department presented at a meeting of the Boston Society for Medical Sciences for preservation in its Journal." Other than the assumption that a department head is necessarily of male gender, this quote is notable in additional ways. As you will see, the date of this resolution-December 19, 1895 with the first issue printed in 1896 -might well be considered the official birthdate of The American Journal of Pathology. In its second year, 1897, the October issue of the Journal proclaims that it "will contain full abstracts of experimental work carried on in the following institutions: the Medical School of Harvard University, the Experimental Laboratories of the Massachusetts General and the Boston City Hospitals, the Physiological and Biological Departments of the Massachusetts Institute of Technology, and Clark University. Papers and abstracts of papers on subjects connected with the Medical Sciences will be welcomed from persons not members of the Society, and if approved by the Council, will be presented at the meetings, and abstracts will be given a place in the Journal." The Journal of the Boston Society of Medical Sciences was thus rich in abstracts, although unlike our current view of abstracts, these often took the The Journal has thus logically evolved to its current focus on the molecular pathobiology of human disease. Within the last year alone, marked content changes have been noted with increasing numbers of publications using novel approaches such as array-based genomic analyses. The first true proteomics papers have also been published within the last twelve months. It is particularly noteworthy that in this (arguably) centennial year, the first drafts of the human genome were reported, and the first genomics and proteomics papers began to appear in our Journal. Without a doubt, papers describing the effects of polymorphisms on disease processes will soon be routinely handled. A particularly exciting development for our field stems from the fact that the increasing reliance on mouse (and fly and worm) biology places many of the advances in pathobiology of disease back into a three-dimensional in vivo context-a context in which understanding of the architecture of disease, a strength of our field becomes once again a major focal point. These changes promise to reinvigorate the critical "bridge" function of experimental pathology, connecting the basic and clinical sciences.
The Birth Date of the Journal and Its Link to

The Recast Editorial Group Looks Forward to Serving Our Authors
The major role of the editors is to ensure uniform high quality, through the peer review process, of manuscripts submitted by our authors. As such, our role is one of service to both readership and authors. Given the in-creased quality and quantity of submissions, elements such as priority rankings have become critical to the final decision and this, at times, can be frustrating to authors. Hopefully, however, all will recognize the value of continuously increasing the quality of the Journal.
Although our current group of editors is recast it is not entirely new. Continuity in the editorial review process will be greatly helped by a group of editors who also served before the most recent transition: Drs. The Journal has also become more international in flavor with approximately 40% of published manuscripts now coming from outside of the United States. Accordingly, for the first time we are fortunate to have Associate Editors located in both Europe and Asia (Drs. Pignatelli and Hirohashi). Recognizing the multidisciplinary nature of the content of many papers, we will increasingly publish commentaries to place manuscripts in a broader context. We are also fortunate that Dr. Fausto has agreed to take responsibility for a new section, "This Month in AJP," which, in shorter form, accomplishes a similar goal of placing into context a number of highlighted articles in each issue. Importantly, however, the editors recognize that while such enhancements increase the accessibility of the content to the readership, the bread and butter of our task is still to ensure the uniformity of quality of the primary manuscripts published. We are fortunate to have a first class editorial office in Bethesda, under the guidance of Managing Editor Priscilla Markwood, to control the logistics of this process.
If one takes the originally assumed 1901 as the founding date of the Journal, our centennial year is thus marked by a recast editorial group with a renewed commitment to further serve our readership and authors and to continue the process of continuous incremental quality enhancement carried out so well by the previous group. It is also marked by a vigorous internationalism, an eye toward increasing accessibility of content to the readership but, most of all, a surrounding revolution in biology with great promise for improved understanding of human disease and enhanced positioning of our field in this process. We are indeed grateful for these opportunities.
